Method of treating seizures using modified release formulations of oxcarbazepine
US7910131B2 · kind B2 · utility
3Cited by
6References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 27, 2008 |
| Grant date | Mar 22, 2011 |
| Priority date | — |
| Expiry date | Feb 13, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2800/56
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Controlled-release preparations of oxcarbazepine and derivatives thereof for once-a-day administration are disclosed. The inventive compositions comprise solubility- and/or release enhancing agents to provide tailored drug release profiles, preferably sigmoidal release profiles. Methods of treatment comprising the inventive compositions are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.